TCWM
VRTX icon

Total Clarity Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Total Clarity Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Buy
1,631
+448
+38% +$199K 0.16% 157
2026
Q1 		$528K Hold
1,183
– – 0.12% 171
2025
Q4 		$536K Sell
1,183
-49
-4% -$21.1K 0.13% 165
2025
Q3 		$483K Sell
1,232
-30
-2% -$12.5K 0.13% 168
2025
Q2 		$562K Buy
1,262
+50
+4% +$23K 0.16% 145
2025
Q1 		$488K Sell
1,212
-25
-2% -$11.7K 0.16% 150
2024
Q4 		$498K Sell
1,237
-12
-1% -$5.56K 0.16% 151
2024
Q3 		$581K Hold
1,249
– – 0.19% 133
2024
Q2 		$585K Sell
1,249
-78
-6% -$33.9K 0.2% 121
2024
Q1 		$555K Buy
1,327
+55
+4% +$23.3K 0.19% 137
2023
Q4 		$518K Sell
1,272
-20
-2% -$7.39K 0.21% 123
2023
Q3 		$449K Buy
1,292
+25
+2% +$8.74K 0.22% 122
2023
Q2 		$446K Buy
1,267
+27
+2% +$9.1K 0.22% 115
2023
Q1 		$391K Sell
1,240
-25
-2% -$7.5K 0.21% 112
2022
Q4 		$365K Sell
1,265
-15
-1% -$4.57K 0.19% 136
2022
Q3 		$371K Hold
1,280
– – 0.23% 131
2022
Q2 		$361K Sell
1,280
-145
-10% -$38.8K 0.19% 132
2022
Q1 		$372K Sell
1,425
-15
-1% -$3.56K 0.2% 135
2021
Q4 		$316K Sell
1,440
-40
-3% -$7.78K 0.14% 153
2021
Q3 		$268K Buy
+1,480
New +$289K 0.13% 178

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Total Clarity Wealth Management's VRTX Position: Q2 2026 in Review

Total Clarity Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 38% in Q2 2026, buying an estimated $199K and bringing the position to 1,631 shares worth $810K. The position accounts for 0.16% of the portfolio, ranked #157.

Total Clarity Wealth Management first reported a position in VRTX in Q3 2021 and has held it in 20 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Total Clarity Wealth Management held 1,631 shares of Vertex Pharmaceuticals worth $810K as of Q2 2026.
  • Total Clarity Wealth Management bought 448 Vertex Pharmaceuticals shares in Q2 2026, an estimated $199K.
  • Vertex Pharmaceuticals made up 0.16% of Total Clarity Wealth Management's portfolio in Q2 2026, its #157 holding.
  • Total Clarity Wealth Management first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.